Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

Conditions: Pancreatic Cancer Interventions: Drug: Irinotecan liposome II combination therapy regimen Sponsors: Peking Union Medical College Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials